Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the U.S. Medicare system
A. Walter, K. Manahan, D. Labarge, G. Phibbs, J. GeislerVolume:
125
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.ygyno.2011.12.036
File:
PDF, 60 KB
english, 2012